Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma (Q37074226)
Jump to navigation
Jump to search
scientific article published on 07 January 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma |
scientific article published on 07 January 2009 |
Statements
1 reference
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma (English)
1 reference
Howard L Kaufman
1 reference
Bret Taback
1 reference
William Sherman
1 reference
Dae Won Kim
1 reference
William H Shingler
1 reference
Dorota Moroziewicz
1 reference
Gail DeRaffele
1 reference
Josephine Mitcham
1 reference
Miles W Carroll
1 reference
Richard Harrop
1 reference
Stuart Naylor
1 reference
Seunghee Kim-Schulze
1 reference
7 January 2009
1 reference
1 reference
7 January 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference